Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 200740
Company: LEADIANT BIOSCI INC
Company: LEADIANT BIOSCI INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CYSTARAN | CYSTEAMINE HYDROCHLORIDE | EQ 0.44% BASE | SOLUTION/DROPS;OPHTHALMIC | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/02/2012 | ORIG-1 | Approval | Type 3 - New Dosage Form | PRIORITY; Orphan |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200740s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/200740Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/200740_cystaran_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/200740Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/25/2022 | SUPPL-3 | Manufacturing (CMC)-Facility |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200740s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/200740Orig1s003ltr.pdf | |
04/24/2020 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200740s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/200740Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
02/25/2022 | SUPPL-3 | Manufacturing (CMC)-Facility | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200740s003lbl.pdf | |
04/24/2020 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200740s001lbl.pdf | |
10/02/2012 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200740s000lbl.pdf |